X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (38535) 38535
Newsletter (3398) 3398
Newspaper Article (1794) 1794
Book Chapter (545) 545
Magazine Article (363) 363
Book / eBook (104) 104
Trade Publication Article (23) 23
Government Document (21) 21
Transcript (13) 13
Web Resource (13) 13
Reference (12) 12
Report (12) 12
Dissertation (9) 9
Conference Proceeding (8) 8
Book Review (5) 5
Publication (2) 2
Paper (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (29532) 29532
male (14900) 14900
female (14755) 14755
respiratory system (9469) 9469
adult (9069) 9069
respiratory tract infections - drug therapy (8788) 8788
middle aged (8522) 8522
respiratory tract diseases (8101) 8101
aged (6688) 6688
child (5994) 5994
anti-bacterial agents - therapeutic use (5982) 5982
research (5940) 5940
health aspects (5385) 5385
care and treatment (5136) 5136
animals (4952) 4952
infections (4789) 4789
adolescent (4774) 4774
infectious diseases (4743) 4743
child, preschool (4656) 4656
asthma (4480) 4480
pneumonia (4398) 4398
respiratory tract infections (4276) 4276
infant (4206) 4206
antibiotics (4058) 4058
children (3971) 3971
pediatrics (3949) 3949
drug therapy (3910) 3910
risk factors (3872) 3872
treatment outcome (3860) 3860
immunology (3588) 3588
mortality (3382) 3382
diagnosis (3175) 3175
microbiology (3138) 3138
pharmacology & pharmacy (3077) 3077
inflammation (3025) 3025
analysis (3009) 3009
medical research (2905) 2905
infection (2880) 2880
patients (2852) 2852
communicable diseases (2705) 2705
medicine (2701) 2701
medicine, general & internal (2580) 2580
respiratory tract infections - microbiology (2559) 2559
drugs (2530) 2530
disease (2516) 2516
medicine & public health (2372) 2372
cancer (2369) 2369
lung diseases (2358) 2358
retrospective studies (2230) 2230
research article (2226) 2226
aged, 80 and over (2140) 2140
medicine, experimental (2130) 2130
critical care medicine (2123) 2123
respiratory diseases (2079) 2079
viruses (2047) 2047
respiratory tract (2019) 2019
epidemiology (1976) 1976
therapy (1946) 1946
prospective studies (1944) 1944
studies (1941) 1941
management (1939) 1939
young adult (1912) 1912
acute disease (1909) 1909
mice (1906) 1906
pulmonary/respiratory (1895) 1895
clinical trials (1886) 1886
cystic fibrosis (1855) 1855
chronic obstructive pulmonary disease (1854) 1854
internal medicine (1818) 1818
coronaviruses (1816) 1816
respiratory-tract infections (1813) 1813
infant, newborn (1759) 1759
review (1750) 1750
respiratory syncytial virus (1708) 1708
abridged index medicus (1660) 1660
bacterial infections - drug therapy (1655) 1655
hospitals (1648) 1648
asthma - drug therapy (1634) 1634
anti-bacterial agents - administration & dosage (1609) 1609
respiratory agents (1595) 1595
lungs (1594) 1594
bacterial pneumonia (1578) 1578
allergy (1571) 1571
influenza (1564) 1564
double-blind method (1539) 1539
administration, inhalation (1530) 1530
usage (1515) 1515
prevention (1509) 1509
microbial sensitivity tests (1508) 1508
multidisciplinary sciences (1491) 1491
covid-19 (1488) 1488
cytokines (1477) 1477
time factors (1452) 1452
proteins (1438) 1438
dosage and administration (1427) 1427
adults (1395) 1395
bacteria (1390) 1390
anti-bacterial agents - pharmacology (1366) 1366
respiratory tract infections - complications (1360) 1360
community-acquired pneumonia (1357) 1357
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (46) 46
Online Resources - Online (12) 12
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
St. Michael's Hospital - Stacks (6) 6
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
West Park Healthcare Centre - Stacks (3) 3
Credit Valley Hospital - Stacks (2) 2
Holland Bloorview Kids Rehabilitation - Stacks (2) 2
Humber River Regional Hospital - Finch Stacks (2) 2
Scarborough Hospital - Birchmount (2) 2
Scarborough Hospital - General (2) 2
Toronto East General Hospital - Stacks (2) 2
Trillium Health Centre - Stacks (2) 2
Women's College Hospital - Stacks (2) 2
Credit Valley Hospital - Reference (1) 1
Gerstein Science - Missing (1) 1
Humber River Regional Hospital - Church Reference (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Providence Healthcare - Reference (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Trillium Health Centre - New Books (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (42097) 42097
Japanese (814) 814
German (555) 555
French (513) 513
Italian (454) 454
Russian (344) 344
Spanish (322) 322
Polish (151) 151
Chinese (122) 122
Portuguese (110) 110
Dutch (49) 49
Romanian (46) 46
Swedish (38) 38
Danish (29) 29
Norwegian (25) 25
Turkish (22) 22
Czech (21) 21
Finnish (16) 16
Hungarian (16) 16
Serbian (16) 16
Croatian (12) 12
Ukrainian (10) 10
Slovak (9) 9
Hebrew (5) 5
Lithuanian (3) 3
Bulgarian (2) 2
Icelandic (2) 2
Arabic (1) 1
Bosnian (1) 1
Korean (1) 1
Nauru (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 12/2016, Volume 11, Issue 12, p. e0167522
In this study, we retrospectively reviewed the clinical experience of patients receiving doripenem-containing regimens for the treatment of healthcare-associated infections (HCAIs... 
IN-VITRO | MULTICENTER | BACTERIAL-INFECTIONS | IMIPENEM-CILASTATIN | EFFICACY | VENTILATOR-ASSOCIATED PNEUMONIA | SAFETY | PSEUDOMONAS-AERUGINOSA | MULTIDISCIPLINARY SCIENCES | SURVEILLANCE | ANTIMICROBIAL ACTIVITY | Soft Tissue Infections - mortality | Urinary Tract Infections - mortality | Humans | Middle Aged | Cross Infection - mortality | Male | Tertiary Care Centers - statistics & numerical data | Hospital Mortality - trends | Respiratory Tract Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Cross Infection - pathology | Respiratory Tract Infections - mortality | Soft Tissue Infections - pathology | Aged, 80 and over | Female | Urinary Tract Infections - microbiology | Urinary Tract Infections - pathology | Retrospective Studies | Soft Tissue Infections - drug therapy | Respiratory Tract Infections - pathology | Intraabdominal Infections - microbiology | Respiratory Tract Infections - drug therapy | Treatment Outcome | Cross Infection - drug therapy | Urinary Tract Infections - drug therapy | Intraabdominal Infections - mortality | Intraabdominal Infections - pathology | Soft Tissue Infections - microbiology | Carbapenems - therapeutic use | Cross Infection - microbiology | Aged | Intraabdominal Infections - drug therapy | APACHE | Infection | Doripenem | Care and treatment | Dosage and administration | Health care | Therapy | Pneumonia | Intensive care | Health services | Medical records | Infections | Urinary tract | Drug resistance | Respiratory tract | Respiratory tract diseases | Urinary tract infections | Urogenital system | Pathogens | Ventilators | Medical research | Statistical analysis | Bacterial infections | Review boards | Mortality | Antimicrobial agents | Patients | Abdomen | Urinary tract diseases | Medicine | Studies | Hospitals | Antibiotics | Pharmacy | Skin | Adults
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2014, Volume 14, Issue 11, pp. 1136 - 1149
.... New viral respiratory tract infections with epidemic potential, such as severe acute respiratory syndrome, swine-origin influenza A H1N1, and Middle East respiratory syndrome coronavirus infection... 
Infectious Disease | INFECTIOUS DISEASES | INFLUENZA-A | ASPERGILLUS-FUMIGATUS | IN-VITRO | VIRUS-INFECTION | A DOUBLE-BLIND | OPEN-LABEL | CRITICALLY-ILL PATIENTS | T-CELLS | SYNDROME CORONAVIRUS | H1N1 VIRUS | Mycoses - epidemiology | Virus Diseases - epidemiology | Biological Therapy - methods | Biological Therapy - trends | Humans | Drug Resistance, Viral | Drug Resistance, Bacterial | Mycoses - microbiology | Virus Diseases - virology | Antifungal Agents - therapeutic use | Respiratory Tract Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Virus Diseases - drug therapy | Respiratory Tract Infections - virology | Drug Resistance, Fungal | Bacterial Infections - microbiology | Drug Therapy - trends | Antifungal Agents - pharmacology | Antiviral Agents - pharmacology | Antiviral Agents - therapeutic use | Bacterial Infections - drug therapy | Drug Discovery - trends | Respiratory Tract Infections - drug therapy | Treatment Outcome | Drug Therapy - methods | Bacterial Infections - epidemiology | Mycoses - drug therapy | Anti-Bacterial Agents - pharmacology | Respiratory Tract Infections - epidemiology | Antiviral agents | Hospitals | Influenza | Mycoses | Development and progression | Bacteria | Cross infection | Nosocomial infections | Drug therapy | Cells | Drug resistance in microorganisms | Severe acute respiratory syndrome | Respiratory agents | Pandemics | Mortality | Respiratory diseases | Viral infections
Journal Article
Respiratory medicine, ISSN 0954-6111, 2016, Volume 117, pp. 190 - 197
.... Methods Electronic searches of PUBMED up to September 2015 were conducted, searching for ‘biofilm’, ‘respiratory tract infection... 
Pulmonary/Respiratory | Biofilm | Inhaled formulation | Airways infections | Topical administration | N-acetylcysteine | NONTYPABLE HAEMOPHILUS-INFLUENZAE | CARDIAC & CARDIOVASCULAR SYSTEMS | COMBINATION | BACTERIAL BIOFILMS | IN-VITRO | STREPTOCOCCUS-PNEUMONIAE | PSEUDOMONAS-AERUGINOSA INFECTION | RESPIRATORY SYSTEM | EXACERBATIONS | ACETYL-L-CYSTEINE | STAPHYLOCOCCUS-AUREUS | THIAMPHENICOL GLYCINATE | Biofilms - drug effects | Bronchiectasis - drug therapy | Humans | Biofilms - growth & development | Administration, Inhalation | Respiratory Tract Infections - drug therapy | Injections, Intramuscular | Pulmonary Disease, Chronic Obstructive - complications | Cystic Fibrosis - complications | Bronchitis, Chronic - drug therapy | Bronchiectasis - complications | Bronchitis - drug therapy | Bronchitis, Chronic - complications | Expectorants - therapeutic use | Acetylcysteine - pharmacology | Bronchitis - complications | Respiratory Tract Infections - complications | Acetylcysteine - administration & dosage | Cystic Fibrosis - drug therapy | Pulmonary Disease, Chronic Obstructive - drug therapy | Acetylcysteine | Respiratory tract diseases | Drug therapy | Health aspects | Pathogens | Pneumonia | Biofilms | Antibiotics | Ear diseases | Cystic fibrosis | Bacteria | Staphylococcus infections | Chronic obstructive pulmonary disease | Bronchitis | Streptococcus infections
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 379, Issue 3, pp. 236 - 249
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 09/2009, Volume 302, Issue 10, pp. 1059 - 1066
Journal Article
Clinical microbiology and infection, ISSN 1198-743X, 2018, Volume 24, Issue 12, pp. 1339.e1 - 1339.e5
...–foetal and focal infections. Little is known about Lm-associated respiratory tract or lung infections... 
Listeria monocytogenes | Listeriosis | Pleural effusion | Immunosuppression | Pneumonia | INFECTIOUS DISEASES | MANAGEMENT | SERIES | SURVEILLANCE | EFFUSION | MICROBIOLOGY | CENTRAL-NERVOUS-SYSTEM | Listeriosis - drug therapy | Sepsis - etiology | Lung Diseases - microbiology | Humans | Middle Aged | Pneumonia, Bacterial - etiology | Male | Lung Diseases - drug therapy | Lung Diseases - etiology | Empyema, Pleural - epidemiology | Listeriosis - epidemiology | Respiratory Tract Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Sepsis - drug therapy | Pleuropneumonia - epidemiology | Aged, 80 and over | Adult | Female | Respiratory Tract Infections - etiology | Retrospective Studies | Pleuropneumonia - drug therapy | Pleuropneumonia - etiology | Pneumonia, Bacterial - microbiology | Listeriosis - complications | Empyema, Pleural - microbiology | Sepsis - epidemiology | Listeria monocytogenes - isolation & purification | Respiratory Tract Infections - drug therapy | Pleuropneumonia - microbiology | Pneumonia, Bacterial - epidemiology | Empyema, Pleural - drug therapy | Listeriosis - microbiology | Pneumonia, Bacterial - drug therapy | Aged | Respiratory Tract Infections - epidemiology | Empyema, Pleural - etiology | Lung Diseases - epidemiology | Sepsis - microbiology | Listeria monocytogenes - drug effects | Pneumonia, Bacterial/etiology | Sepsis/drug therapy | Lung Diseases/epidemiology | Empyema, Pleural/epidemiology | Sepsis/microbiology | Listeriosis/drug therapy | Pneumonia, Bacterial/epidemiology | Lung Diseases/microbiology | Lung Diseases/etiology | Life Sciences | Listeriosis/microbiology | Pneumonia, Bacterial/drug therapy | Sepsis/epidemiology | Pleuropneumonia/epidemiology | Pleuropneumonia/etiology | Respiratory Tract Infections/drug therapy | Lung Diseases/drug therapy | Empyema, Pleural/drug therapy | Listeria monocytogenes/isolation & purification | Pleuropneumonia/drug therapy | Listeria monocytogenes/drug effects | Respiratory Tract Infections/epidemiology | Pleuropneumonia/microbiology | Bacteriology | Human health and pathology | Microbiology and Parasitology | Infectious diseases | Respiratory Tract Infections/etiology | Respiratory Tract Infections/microbiology | Listeriosis/complications | Empyema, Pleural/etiology | Empyema, Pleural/microbiology | Listeriosis/epidemiology | Pneumonia, Bacterial/microbiology | Anti-Bacterial Agents/therapeutic use | Sepsis/etiology
Journal Article
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 2017, Volume 12, Issue 3, p. e0174584
.... The prescription of antibiotics for acute lower respiratory tract infections was compared to the national S3 guideline cough from the German Society of General Practitioners and Family Medicine... 
PHYSICIANS | MULTIDISCIPLINARY SCIENCES | Primary Health Care - methods | Guideline Adherence - statistics & numerical data | Practice Patterns, Physicians' - standards | Cough - drug therapy | Humans | Middle Aged | Male | Primary Health Care - standards | Young Adult | Anti-Bacterial Agents - therapeutic use | Community-Acquired Infections - drug therapy | General Practitioners - standards | Family Practice - standards | Aged, 80 and over | Adult | Female | Family Practice - statistics & numerical data | General Practitioners - statistics & numerical data | Acute Disease | Guideline Adherence - standards | Respiratory Tract Infections - drug therapy | Drug Prescriptions - standards | Drug Prescriptions - statistics & numerical data | Pneumonia - drug therapy | Bronchitis - drug therapy | Adolescent | Aged | Germany | Practice Guidelines as Topic | Respiratory tract infections | Drug resistance in microorganisms | Care and treatment | Antibiotics | Primary health care | Dosage and administration | Management | Research | Pneumonia | Physicians | Health services | Data processing | Infections | Electronic medical records | Patients | Primary care | Cough | Guidelines | Family physicians | Respiratory tract | Hospitals | Pharmacy | Antibiotic resistance | Respiratory tract diseases | Bronchitis | Prescriptions
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 2017, Volume 61, Issue 9
Journal Article